These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20062082)

  • 1. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.
    Baert JL; Monte D; Verreman K; Degerny C; Coutte L; de Launoit Y
    Oncogene; 2010 Mar; 29(12):1810-20. PubMed ID: 20062082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
    Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
    Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation.
    Bojović BB; Hassell JA
    DNA Cell Biol; 2008 Jun; 27(6):289-305. PubMed ID: 18447755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
    Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
    Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells.
    Yi C; Li S; Chen X; Wiemer EA; Wang J; Wei N; Deng XW
    Cancer Res; 2005 Jul; 65(13):5835-40. PubMed ID: 15994960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
    Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
    J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
    Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
    Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
    Carrero ZI; Kollareddy M; Chauhan KM; Ramakrishnan G; Martinez LA
    Oncotarget; 2016 Mar; 7(11):12554-67. PubMed ID: 26871468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.
    Li DQ; Ohshiro K; Reddy SD; Pakala SB; Lee MH; Zhang Y; Rayala SK; Kumar R
    Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17493-8. PubMed ID: 19805145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
    Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
    J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
    Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
    J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group members.
    Verger A; Baert JL; Verreman K; Dewitte F; Ferreira E; Lens Z; de Launoit Y; Villeret V; Monté D
    Nucleic Acids Res; 2013 May; 41(9):4847-59. PubMed ID: 23531547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
    Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
    Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain.
    Baert JL; Beaudoin C; Coutte L; de Launoit Y
    J Biol Chem; 2002 Jan; 277(2):1002-12. PubMed ID: 11682477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two functionally distinct domains responsible for transactivation by the Ets family member ERM.
    Laget MP; Defossez PA; Albagli O; Baert JL; Dewitte F; Stehelin D; de Launoit Y
    Oncogene; 1996 Mar; 12(6):1325-36. PubMed ID: 8649835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERM transcription factor contains an inhibitory domain which functions in sumoylation-dependent manner.
    Degerny C; de Launoit Y; Baert JL
    Biochim Biophys Acta; 2008 Mar; 1779(3):183-94. PubMed ID: 18243147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth.
    Choi HH; Phan L; Chou PC; Su CH; Yeung SC; Chen JS; Lee MH
    Oncotarget; 2015 Aug; 6(23):19721-34. PubMed ID: 26254224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.
    Migliorini D; Bogaerts S; Defever D; Vyas R; Denecker G; Radaelli E; Zwolinska A; Depaepe V; Hochepied T; Skarnes WC; Marine JC
    J Clin Invest; 2011 Apr; 121(4):1329-43. PubMed ID: 21403399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.